Page 7 of 8
New Journal of Chemistry
Please do not adjust margins
Journal Name
ARTICLE
DOI: 10.1039/C8NJ02960A
T. Ohshima and M. Shibasaki, Tetrahedron 2002, 58, 75; e) B.
Plancq and T. Ollevier, Chem. Commun., 2012, 48, 3806 ; f) H.
Bao, J. Wu, H. Li, Z. Wang, T. You and K. Ding, Eur. J. Org. Chem.
2010, 2010, 6722.
epoxides, trans-epoxide and meso-epoxide with anilines to
synthesize the pharmaceutically important β-amino-α-hydroxyl
ester and β-amino-alcohols derivatives (yield up to 95%, with
excellent enantioselectivity upto 99%). This reaction protocol
was extended for the synthesis of pharmaceutically active
oxazolidine ring system. The catalyst was also recycled and
successfully reused five times with retention of configuration.
7
8
574; b) B. M. Trost and M. L. Crawley, Chem. Rev., 2003, 103
,
,
,
Rev., 2017, 117, 4528.
a) M. Kumar, R. I. Kureshy, D. Ghosh, N. H. Khan, S. H. R. Abdi,
H. C. Bajaj, ChemCatChem, 2013, 5, 2336; b) R. I. Kureshy, K. J.
Prathap, M. Kumar, P. K. Bera, N. H. Khan, S. H. R. Abdi and H.
C. Bajaj, Tetrahedron, 2011, 67, 8300; c) M. K. Choudhary, R.
Tak, R. I. Kureshy, A. Ansari, N. H. Khan, S. H.R. Abdi and H. C.
Bajaj, J. Mol. Catal. A: Chem, 2015, 409, 85; d) R. Tak, M.
Kumar, R. I. Kureshy, M. K. Choudhary, N. H. Khan, S. H. R. Abdi
and H. C. Bajaj, RSC Adv. 2016, 6, 7693; e) M. Kumar, R.
I.Kureshy, A. K. Shah, A. Das, N. H. Khan, S. H. R. Abdi, H. C.
Bajaj, J. Org. Chem., 2013, 78, 9076.
Conflicts of interest
“There are no conflicts to declare”.
Acknowledgements
(CSMCRI Communication No. 076 /2018). Rajkumar Tak and RIK
are thankful to UGC and HCP-0009 for financial assistance.
Rajkumar Tak is thankful to AcSIR for Ph.D. Registration.
Authors are also thankful to Analytical Science and centralized
instrument facilities for providing instruments facilities.
9
R. Tak, M. Kumar, T. Menapara, N. Gupta, R. I. Kureshy, N. H.
Khan and E. Suresh, Adv. Synth. Catal., 2017, 359, 3990.
10 a) J. Wang, F. D. Rochon, Y. Yang, L. Hua, M. M. Kaysera,
Tetrahedron: Asymmetry, 2007, 18, 1115; b) D. J. Burkhart, B.
L. Barthel, G. C. Post, B. T. Kalet, J. W. Nafie, R. K. Shoemaker,
T. H. Koch, J. Med. Chem. 2006, 49, 7002; c) G. C. Post, B. L.
Barthel, D. J. Burkhart, J. R. Hagadorn and T. H. Koch, J. Med.
Chem. 2005, 48, 7648.
Notes and references
11 a) P. Yana and H. Jinga, Adv. Synth. Catal. 2009, 351, 1325; b)
L. Jin, Y. Huang, H. Jing, T. Chang, P. Yan, Tetrahedron:
Asymmetry, 2008, 19, 1947; c) S. I. Murahashi, S. Noji, N.
Komiya, Adv. Synth. Catal. 2004, 346, 195.
12 a) E. N. Jacobsen, Acc. Chem. Res., 2000, 33, 421; b) B. Gao,
M. Xie, A. Sun, X. Hu, X. Ding, X. Liu, L. Lin and X. Feng, Adv.
Synth. Catal.,2012, 354, 1509; c) M. Meguro, N. Asaob and Y.
Yamamoto, J. Chem. Soc., Perkin Trans. 1, 1994, 0, 2597; d)
Karl B. Hansen, James L. Leighton and Eric N. Jacobsen, J. Am.
Chem. Soc., 1996, 118 ,10924; e) J. Auge and F. Leroy,
Tetrahedron Lett.,1996, 37, 7715; f) A. T. Placzek, J. L.
Donelson, R. Trivedi, R. A. Gibbs and S. K. De, Tetrahedron
Lett.,2005, 46, 9029.
1
a) E. M. McGarrigle and D. G. Gilheany, Chem. Rev., 2005, 105,
1563; b) Q.-H. Xia, H.-Q. Ge, C.-P. Ye, Z.-M. Liu and K.-X. Su,
Chem. Rev., 2005, 105, 1603; c) O. A. Wong and Y. Shi, Chem.
Rev., 2008, 108, 3958; d) E. N. Jacobsen, Acc. Chem. Res.,
2000, 33, 421.
2
a) D. J. Ager, I. Prakash and D. R. Schaad, Chem. Rev., 1996, 96
835; b) S. C. Bergmeier, Tetrahedron, 2000, 56, 2561; c) M.
Yamashita, K. Yamada and K. Tomioka, Org. Lett., 2005,
2369; d) S. Hashiguchi, A. Kawada and H. Natsugari, J. Chem.
,
7
,
Soc. Perkin Trans.,1991,
1995, 95, 1859.
1, 2435; e) S. Knapp, Chem. Rev.,
3
4
a) Q. Wang, W. Huang, H. Yuan, Q. Cai, L. Chen, H. Lv and X.
Zhang, J. Am. Chem. Soc., 2014, 136, 16120; b) C. G. Goodman,
D. T. Do and J. S. Johnson, Org. Lett., 2013, 15, 2446; d) K. C.
Nicolaou, W. M. Dai and R. K. Guy, Angew. Chem. Int. Ed. Engl.,
1994, 33, 15; Angew. Chem. 1994, 106, 38; e) H. Suda, T.
Takita, T. Aoyagi and H. Umezawa, J. Antibiot., 1976, 29, 100;
f) I. Saiki, J. Murata, K. Watanabe, H. Fujii, F. Abe and I. Azuma,
Jpn. J. Cancer Res., 1989, 80, 873.
a) M. D. Gill, A. N. Pegg and C. M. Rayner, Tetrahedron Lett.
1995, 36, 8327; b) M. C. Wani, H. L. Taylor, M. E. Wall, P.
Coggon and A. T. McPhail, J. Am. Chem. Soc. 1971, 93, 2325;
c) H. Suda, T. Takita, T. Aoyagi, H. Umezawa, J. Antibiot. 1976,
29, 600; d) H. J. Ha, G. S. Park, Y. G. Ahn, G. S. Lee, Bioorg. Med.
Chem. Lett., 1998,
8, 1619; e) D. G. I. Kingston, Chem.
Commun., 2001,2001, 867; f) S. B. Horwitz, J. Nat. Prod., 2004,
67, 136.
5
6
a) G. Bartoli, M. Bosco, A. Carlone, M. Locatelli, M.
Massaccesi, P. Melchiorre and L. Sambri, Org. Lett. 2004, 6,
2173; b) R. Tak, M. Kumar, T. Menapara, M. K. Choudhary, R.
I. Kureshy and N. H. Khan, ChemCatChem, 2016, , 1.
8
a) R. I. Kureshy, M. Kumar, S. Agrawal, N. H. Khan, B. Dangi, S.
H. R. Abdi and H. C. Bajaj, Chirality 2011, 23, 76; b) K. Arai, M.
M. Salter, Y. Yamashita and S. Kobayashi, Angew. Chem. 2007,
119, 973; Angew. Chem. Int. Ed. 2007, 46, 955; c) K. Tanaka, S.
Oda and M. Shiro, Chem. Commun., 2008, 0, 820; d) A. Sekine,
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 7
Please do not adjust margins